{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T11:46:14Z","timestamp":1765626374753,"version":"3.48.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Hebei Natural Science Foundation","award":["H2024206009"],"award-info":[{"award-number":["H2024206009"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81901290"],"award-info":[{"award-number":["81901290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05606-w","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T11:41:55Z","timestamp":1765626115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myeloid Irf5 Deficiency Enhances the Therapeutic Efficacy of IMD-0354 in a TDP-25-Induced Neurodegeneration Model"],"prefix":"10.1007","volume":"63","author":[{"given":"Yuanyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lishuang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"issue":"10360","key":"5606_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G (2022) Amyotrophic lateral sclerosis. Lancet 400(10360):1363\u20131380","journal-title":"Lancet"},{"issue":"26","key":"5606_CR2","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1523\/JNEUROSCI.0536-20.2020","volume":"40","author":"K Dutta","year":"2020","unstructured":"Dutta K, Thammisetty SS, Boutej H, Bareil C, Julien JP (2020) Mitigation of ALS pathology by neuron-specific inhibition of nuclear factor kappa B signaling. J Neurosci 40(26):5137\u20135154","journal-title":"J Neurosci"},{"issue":"12","key":"5606_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11910-018-0901-z","volume":"18","author":"R Garcia-Santibanez","year":"2018","unstructured":"Garcia-Santibanez R, Burford M, Bucelli RC (2018) Hereditary motor neuropathies and amyotrophic lateral sclerosis: a molecular and clinical update. Curr Neurol Neurosci Rep 18(12):93","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"5606_CR4","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","volume":"29","author":"DA Amado","year":"2021","unstructured":"Amado DA, Davidson BL (2021) Gene therapy for ALS: a review. Mol Ther 29(12):3345\u20133358","journal-title":"Mol Ther"},{"issue":"8","key":"5606_CR5","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.3390\/ijms22083875","volume":"22","author":"E K\u00e4llstig","year":"2021","unstructured":"K\u00e4llstig E, McCabe BD, Schneider BL (2021) The links between ALS and NF-\u03baB. Int J Mol Sci 22(8):3875","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5606_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8(1):267","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"5606_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00401-016-1548-y","volume":"132","author":"L Zondler","year":"2016","unstructured":"Zondler L, M\u00fcller K, Khalaji S, Bliederh\u00e4user C, Ruf WP, Grozdanov V et al (2016) Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol 132(3):391\u2013411","journal-title":"Acta Neuropathol"},{"issue":"1","key":"5606_CR8","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.1038\/s41598-018-25007-5","volume":"8","author":"H Ederle","year":"2018","unstructured":"Ederle H, Funk C, Abou-Ajram C, Hutten S, Funk EBE, Kehlenbach RH, Bailer SM, Dormann D (2018) Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1\/CRM1. Sci Rep. 8(1):7084","journal-title":"Sci Rep."},{"key":"5606_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25767-0","volume":"8","author":"Y Khalfallah","year":"2018","unstructured":"Khalfallah Y, Kuta R, Grasmuck C, Prat A, Durham HD, Vande Velde C (2018) TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci Rep 8:7551","journal-title":"Sci Rep"},{"issue":"6","key":"5606_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","volume":"34","author":"HP Nguyen","year":"2018","unstructured":"Nguyen HP, van Broeckhoven C, van der Zee J (2018) ALS Genes in the genomic era and their implications for FTD. Trends Genet 34(6):404\u2013423","journal-title":"Trends Genet"},{"issue":"1","key":"5606_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12974-018-1350-y","volume":"15","author":"SS Thammisetty","year":"2018","unstructured":"Thammisetty SS, Pedragosa J, Weng YC, Calon F, Planas A, Kriz J (2018) Age-related deregulation of TDP-43 after stroke enhances NF-\u03baB-mediated inflammation and neuronal damage. J Neuroinflammation 15(1):312","journal-title":"J Neuroinflammation"},{"issue":"18","key":"5606_CR12","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0900688106","volume":"106","author":"Y-J Zhang","year":"2009","unstructured":"Zhang Y-J, Xu Y-F, Cook C, Gendron TF, Roettges P, Link CD, Lin W-L, Tong J et al (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A 106(18):7607\u20137612","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"5606_CR13","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.M809462200","volume":"284","author":"LM Igaz","year":"2009","unstructured":"Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y, Neumann M, Trojanowski JQ et al (2009) Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J Biol Chem 284(13):8516\u20138524","journal-title":"J Biol Chem"},{"issue":"2","key":"5606_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neulet.2012.10.003","volume":"530","author":"K Hong","year":"2012","unstructured":"Hong K, Li Yi, Duan W, Guo Y, Jiang H, Li W, Li C (2012) Full-length TDP-43 and its C-terminal fragments activate mitophagy in NSC34 cell line. Neurosci Lett 530(2):144\u2013149","journal-title":"Neurosci Lett"},{"issue":"281","key":"5606_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuroscience.2014.09.043","volume":"5","author":"Y Liu","year":"2014","unstructured":"Liu Y, Duan W, Guo Y, Li Z, Han H, Zhang S, Yuan P, Li C (2014) A new cellular model of pathological TDP-43: The neurotoxicity of stably expressed CTF25 of TDP-43 depends on the proteasome. Neuroscience 5(281):88\u201398","journal-title":"Neuroscience"},{"key":"5606_CR16","doi-asserted-by":"crossref","unstructured":"Yu C-H, Davidson S, Harapas CR, Hilton2 JB, Mlodzianoski MJ, Laohamonthonkul P, Louis C, Ren R et al (2020) TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS\/STING in ALS. Cell 183 (3) 636-649.e18","DOI":"10.1016\/j.cell.2020.09.020"},{"issue":"5","key":"5606_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ng.132","volume":"40","author":"E Kabashi","year":"2008","unstructured":"Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Velde CV, Bouchard J-P, Lacomblez L et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40(5):572\u2013574","journal-title":"Nat Genet"},{"issue":"1","key":"5606_CR18","doi-asserted-by":"publisher","first-page":"112581","DOI":"10.1016\/j.yexcr.2021.112581","volume":"403","author":"F Hikage","year":"2021","unstructured":"Hikage F, Lennikov A, Mukwaya A, Lachota M, Ida Y, Utheim TP, Chen DF, Huang H et al (2021) NF-\u03baB activation in retinal microglia is involved in the inflammatory and neovascularization signaling in laser-induced choroidal neovascularization in mice. Exp Cell Res 403(1):112581","journal-title":"Exp Cell Res"},{"issue":"16","key":"5606_CR19","doi-asserted-by":"publisher","first-page":"e98697","DOI":"10.15252\/embj.201798697","volume":"37","author":"NO Alami","year":"2018","unstructured":"Alami NO, Schurr C, Heuvel FO, Tang L, Li Q, Tasdogan A, Kimbara A, Nettekoven M et al (2018) NF-\u03baB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J 37(16):e98697","journal-title":"EMBO J"},{"issue":"9","key":"5606_CR20","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/febs.14654","volume":"286","author":"H Almuttaqi","year":"2019","unstructured":"Almuttaqi H, Udalova IA (2019) Advances and challenges in targeting IRF5, a key regulator of inflammation. FEBS J 286(9):1624\u20131637","journal-title":"FEBS J"},{"issue":"2","key":"5606_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/ejn.13778","volume":"47","author":"A Al Mamun","year":"2018","unstructured":"Al Mamun A, Chauhan A, Yu H, Xu Y, Sharmeen R, Liu F (2018) Interferon regulatory factor 4\/5 signaling impacts on microglial activation after ischemic stroke in mice. Eur J Neurosci 47(2):140\u2013149","journal-title":"Eur J Neurosci"},{"issue":"1798","key":"5606_CR22","doi-asserted-by":"publisher","first-page":"148155","DOI":"10.1016\/j.brainres.2022.148155","volume":"1","author":"Y Li","year":"2023","unstructured":"Li Y, Lishuang Yu, Liu C, Duan W, Zhang S, Li Z, Yi Le, Guo M et al (2023) IRF5 knockdown reverses TDP-related phenotypes partially by increasing TBK1 expression. Brain Res 1(1798):148155","journal-title":"Brain Res"},{"issue":"8","key":"5606_CR23","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/1535-7163.MCT-16-0866","volume":"16","author":"Ao Jian-Yang","year":"2017","unstructured":"Jian-Yang Ao, Xiao-Dong Z, Zong-Tao C, Hao C, Yuan-Yuan Z, Ke-Zhi Z, Ling-Qun K, Ning Z et al (2017) Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma. Mol Cancer Ther 16(8):1544\u20131554","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"5606_CR24","doi-asserted-by":"publisher","first-page":"112467","DOI":"10.1016\/j.yexcr.2020.112467","volume":"399","author":"Li Yuanyuan","year":"2021","unstructured":"Yuanyuan Li, Yakun L, Zhongyao Li, Le Yi, Weisong D, Guo Moran Bu, Hui LC (2021) Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis. Exp Cell Res 399(2):112467","journal-title":"Exp Cell Res"},{"issue":"12","key":"5606_CR25","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1084\/jem.20111313","volume":"208","author":"V Swarup","year":"2011","unstructured":"Swarup V, Phaneuf D, Dupr\u00e9 N, Petri S, Strong M, Kriz J, Julien J-P (2011) Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor \u03baB-mediated pathogenic pathways. J Exp Med 208(12):2429\u20132447","journal-title":"J Exp Med"},{"issue":"49","key":"5606_CR26","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.1418516111","volume":"111","author":"J Ren","year":"2014","unstructured":"Ren J, Chen X, Chen ZJ (2014) IKK\u03b2 is an IRF5 kinase that instigates inflammation. Proc Natl Acad Sci U S A 111(49):17438\u201317443","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5606_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s13311-016-0499-2","volume":"14","author":"K Dutta","year":"2017","unstructured":"Dutta K, Patel P, Rahimian R, Phaneuf D, Julien J-P (2017) Withania somnifera reverses transactive response DNA binding protein 43 proteinopathy in a mouse model of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration. Neurotherapeutics 14(2):447\u2013462","journal-title":"Neurotherapeutics"},{"issue":"1","key":"5606_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1158\/0008-5472.CAN-05-0741","volume":"66","author":"A Tanaka","year":"2006","unstructured":"Tanaka A, Muto S, Konno M, Itai A, Matsuda H (2006) A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition. Cancer Res 66(1):419\u2013426","journal-title":"Cancer Res"},{"issue":"19","key":"5606_CR29","first-page":"6424","volume":"63","author":"BJ Barnes","year":"2003","unstructured":"Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM (2003) Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res 63(19):6424\u20136431","journal-title":"Cancer Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05606-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05606-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05606-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T11:41:56Z","timestamp":1765626116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05606-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5606"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05606-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Second Hospital of Hebei Medical University, Hebei, China (No. 2024-R061) and conformed with the standards set by the Declaration of Helsinki. Written informed consent was obtained from all participants.All procedures involving animals were reviewed and approved by the Animal Ethical and Welfare Committee of the Second Hospital of Hebei Medical University (Protocol No. 2024-AE054). Experiments adhered to the Laboratory Animal Management Regulations of the Ministry of Science and Technology of the People\u2019s Republic of China, consistent with the guidelines outlined in the NIH Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}